Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer

Lutetium-177-PSMA ([177Lu]-PSMA-617), a radiolabeled small molecule, binds with high affinity to prostate-specific membrane antigen (PSMA), enabling targeted radiation therapy to metastatic prostate lesions. Our objective was to retrospectively analyze the activity of [177Lu]-PSMA-617 given off-tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadot, Moran, Davidson, Tima, Aharon, Margalit, Atenafu, Eshetu G., Malki, Avraham, Levartovsky, Meital, Saad, Akram, Domachevsky, Liran, Berger, Raanan, Leibowitz, Raya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281592/
https://www.ncbi.nlm.nih.gov/pubmed/32357427
http://dx.doi.org/10.3390/cancers12051078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281592/
https://www.ncbi.nlm.nih.gov/pubmed/32357427
http://dx.doi.org/10.3390/cancers12051078

Ejemplares similares